Sir Christopher Martin Dobson (8 October 1949 – 8 September 2019) was a British chemist and structural biologist whose work reshaped understanding of how proteins fold, misfold and form toxic aggregates. He held the John Humphrey Plummer Professorship of Chemical and Structural Biology at the University of Cambridge and served as Master of St John’s College. Through a combination of fundamental physical chemistry, biophysics and collaborative clinical engagement, Dobson connected molecular mechanisms of folding with the origins of neurodegenerative disease.
Research focus and methods
Dobson’s group investigated the pathways by which polypeptide chains adopt their functional three‑dimensional structures and the conditions under which they instead assemble into ordered, insoluble amyloid fibrils. His work emphasised the folding energy landscape, the kinetics of misfolding and the role of molecular chaperones and small molecules in modulating aggregation. The laboratory used a mix of experimental and theoretical tools, including nuclear magnetic resonance, mass spectrometry, single‑molecule techniques and computational modelling, to dissect intermediate states, aggregation nuclei and mechanisms of toxicity.
- Core topics: protein folding mechanisms, amyloid formation, molecular chaperones, aggregation inhibitors and cellular proteostasis.
- Biomedical relevance: studies informed understanding of Alzheimer’s and Parkinson’s diseases and systemic amyloidoses, and helped guide efforts toward diagnostic markers and therapeutic strategies.
Career, leadership and honours
Dobson spent most of his career at the University of Cambridge where he led a large interdisciplinary group in chemical biology and structural biology. He was elected a Fellow of the Royal Society (FRS) and a Fellow of the Academy of Medical Sciences (FMedSci), and was knighted for services to science. He combined research with teaching and college leadership as Master of St John’s, supporting graduate training and cross‑disciplinary initiatives.
Impact, translation and mentorship
Beyond laboratory discoveries, Dobson was known for fostering collaborations among chemists, biologists and clinicians and for promoting translation of basic biophysical insights into potential diagnostics and treatments. He played an active role in initiatives such as the Cambridge Centre for Misfolding Diseases and collaborated with academic and industrial partners. He published extensively, was widely cited, and mentored many students and postdoctoral researchers who continue to work in academia, biotechnology and medicine.
Death and sources
Dobson died in London on 8 September 2019 of cancer. Contemporary tributes and institutional announcements noted both his scientific contributions and his role as a mentor and leader. Further information and official notices are available from institutional and news pages: biography, professorship details, University of Cambridge profile, St John’s College statement, news coverage and additional remarks.